News FDA to Review Once-Nightly Sodium Oxybate Formulation for Narcolepsy By Brian Park, PharmD Publish Date March 1, 2021
Drugs in the Pipeline Lumateperone sNDAs Submitted for Bipolar Depression Indication By Brian Park, PharmD Publish Date February 22, 2021
News Sildenafil, Trazodone Tablets Recalled After Being Packaged Together Publish Date December 10, 2020
News Hetlioz Approved for Nighttime Sleep Disturbances in Smith-Magenis Syndrome By Brian Park, PharmD Publish Date December 3, 2020
News Additional Administration Option Approved for Nuplazid Capsules By Brian Park, PharmD Publish Date December 3, 2020
News Disproportionality Signal Found for Suicidality in Finasteride Users Publish Date November 23, 2020
News Fluvoxamine Evaluated in Patients With Mild COVID-19 By Cassandra Pardini, PharmD Publish Date November 20, 2020
Drugs in the Pipeline FDA Issues Complete Response Letter for Olanzapine/Samidorphan By Diana Ernst, RPh Publish Date November 18, 2020
News Review Assesses Pharmacotherapies for Adult ADHD By Cassandra Pardini, PharmD Publish Date November 17, 2020
News FDA Authorizes Digital Therapeutic for Sleep Disturbance in PTSD By Brian Park, PharmD Publish Date November 9, 2020
News Valerian Quality, Storage Issues May Affect Sleep Outcomes By Cassandra Pardini, PharmD Publish Date November 6, 2020
Drugs in the Pipeline Application for Long-Acting Schizophrenia Treatment Submitted By Brian Park, PharmD Publish Date November 3, 2020
News Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions Publish Date October 19, 2020
News Wakix Indication Expanded to Include Cataplexy Treatment By Brian Park, PharmD Publish Date October 15, 2020
Drugs in the Pipeline FDA Committees Vote on Novel Therapy for Schizophrenia, Bipolar I Disorder By Diana Ernst, RPh Publish Date October 13, 2020
Drugs in the Pipeline Idiopathic Hypersomnia Study Evaluating Xywav Meets End Points By Brian Park, PharmD Publish Date October 9, 2020
Safety Alerts and Recalls FDA Requires Boxed Warning Update for Benzodiazepines By Brian Park, PharmD Publish Date September 24, 2020
Drugs in the Pipeline Transdermal Cannabidiol Gets Orphan Drug Status for 22q11.2 Deletion Syndrome By Brian Park, PharmD Publish Date September 18, 2020